Autologous blood stem cell transplantation in high risk myeloma

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial.

Leukemia·2017

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

[Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].

La Revue de medecine interne·2015

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.

Bone marrow transplantation·2014

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

Leukemia·2013

Minor clone provides a reservoir for relapse in multiple myeloma.

Leukemia·2012

GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis.

Bone marrow transplantation·2026

GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS.

Bone marrow transplantation·2026

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

Bone marrow transplantation·2026

Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.

Bone marrow transplantation·2026

Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT.

Bone marrow transplantation·2026

Pregnancy outcomes in women conceiving after hematopoietic stem cell transplantation versus conventional chemotherapy for childhood or adolescent acute leukemia.

Bone marrow transplantation·2026

Impact of antibody-mediated rejection detected on one-year protocol biopsies on long-term kidney allograft survival.

Frontiers in medicine·2026

Urine inflammatory protein levels decrease following kidney transplantation.

Frontiers in medicine·2026

Clinical Evolution, Outcomes, and Emerging Preservation Technologies in Pancreas and Islet Transplantation.

Journal of clinical medicine·2026

Solid Organ Transplantation and Body Contouring Surgery: A Case Series and Single-Center Experience.

Journal of clinical medicine·2026

Hrd1 alleviates fatty liver ischemia-reperfusion injury by regulating the phenotypic polarization of Kupffer cells.

The international journal of biochemistry & cell biology·2026

Pulmonary Cryobiopsy in the ICU: Clinical Utility in a Critically Ill Lung Transplant Recipient.

Open respiratory archives·2026

Related Experiment Videos

Autologous blood stem cell transplantation in high risk myeloma

Related Concept Videos

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial.

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma.

[Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

Minor clone provides a reservoir for relapse in multiple myeloma.

GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis.

GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS.

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.

Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT.

Pregnancy outcomes in women conceiving after hematopoietic stem cell transplantation versus conventional chemotherapy for childhood or adolescent acute leukemia.

Impact of antibody-mediated rejection detected on one-year protocol biopsies on long-term kidney allograft survival.

Urine inflammatory protein levels decrease following kidney transplantation.

Clinical Evolution, Outcomes, and Emerging Preservation Technologies in Pancreas and Islet Transplantation.

Solid Organ Transplantation and Body Contouring Surgery: A Case Series and Single-Center Experience.

Hrd1 alleviates fatty liver ischemia-reperfusion injury by regulating the phenotypic polarization of Kupffer cells.

Pulmonary Cryobiopsy in the ICU: Clinical Utility in a Critically Ill Lung Transplant Recipient.

Related Experiment Videos

Autologous blood stem cell transplantation in high risk myeloma

Related Concept Videos

Related Articles